E522-0142 Screening compound: N-[3-(3,5-dimethylpiperidin-1-yl)propyl]-2-[(2-ethoxyphenyl)methyl]-3-methyl-1-oxo-1H,2H,3H,4H-pyrazino[1,2-a]indole-3-carboxamide

E522-0142 Screening compound: N-[3-(3,5-dimethylpiperidin-1-yl)propyl]-2-[(2-ethoxyphenyl)methyl]-3-methyl-1-oxo-1H,2H,3H,4H-pyrazino[1,2-a]indole-3-carboxamide
E522-0142 Screening compound: N-[3-(3,5-dimethylpiperidin-1-yl)propyl]-2-[(2-ethoxyphenyl)methyl]-3-methyl-1-oxo-1H,2H,3H,4H-pyrazino[1,2-a]indole-3-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound E522-0142
N-[3-(3,5-dimethylpiperidin-1-yl)propyl]-2-[(2-ethoxyphenyl)methyl]-3-methyl-1-oxo-1H,2H,3H,4H-pyrazino[1,2-a]indole-3-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E522-0142

Molecular Formula

C32H42N4O3 (C32 H42 N4 O3)

Compound Name

N-[3-(3,5-dimethylpiperidin-1-yl)propyl]-2-[(2-ethoxyphenyl)methyl]-3-methyl-1-oxo-1H,2H,3H,4H-pyrazino[1,2-a]indole-3-carboxamide

IUPAC name

N-[3-(35-dimethylpiperidin-1-yl)propyl]-2-[(2-ethoxyphenyl)methyl]-3-methyl-1-oxo-1H2H3H4H-pyrazino[12-a]indole-3-carboxamide

SMILES

CCOc1c(CN(C(C)(Cn(c2c3)c4c3cccc4)C(NCCCN3CC(C)CC(C)C3)=O)C2=O)cccc1

InChI

InChI=1S/C32H42N4O3/c1-5-39-29-14-9-7-12-26(29)21-36-30(37)28-18-25-11-6-8-13-27(25)35(28)22-32(36,4)31(38)33-15-10-16-34-19-23(2)17-24(3)20-34/h6-9,11-14,18,23-24H,5,10,15-17,19-22H2,1-4H3,(H,33,38)

InChI Key

LDEHHPIHFDJZQO-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14894515

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

530.71

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

5.425

Distribution Coefficient, logD

2.820

Water Solubility, LogSw

-5.87

Polar Surface Area

51.913

Acid Dissociation Constant (pKa)

14.57

Base Dissociation Constant (pKb)

10.00

Number of Chiral Centers

3.00

Percent sp3 carbon bonding

50.00

E522-0142 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Cyclic Ugi PPI Library (9586 compounds)

MCL1 Targeted Library (12200 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Protein-Protein Interaction Library (218420 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds
  • Mimetics
Therapeutical areas:
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic

References: we are preparing a list of scientific research reports with E522-0142 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E522-0142?
Check Price and Availability of E522-0142, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E522-0142 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E522-0142
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E522-0142
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E522-0142 available by request